PR91464

CLEVELAND, Sept. 7, 2021 /PRNewswire=KYODO JBN/ --

MIM Software Inc., a leading global provider of medical imaging software,

announced today new innovations to MIM SurePlan(TM) MRT, its software package

for Molecular Radiotherapy.

Logo - https://mma.prnewswire.com/media/709760/MIM_Software_Logo.jpg

MIM SurePlan MRT has received CE Mark approval for new artificial intelligence

(AI) segmentation models, which simplify the contouring process for dosimetry.

AI segmentation provides significant time savings and enhanced results compared

to manual and atlas-based segmentation.

In addition to these new AI segmentation models, MIM SurePlan MRT now includes

two single timepoint methods -- the Hanscheid approach and the

prior-information approach.

The Hanscheid approach uses a single SPECT/CT acquired around a carefully

chosen time after each cycle of therapy to calculate the absorbed dose. The

prior information approach uses time-activity curve information from multiple

SPECT/CTs after the first cycle to calculate the dose for the remaining cycles,

using only a single SPECT/CT at each of the remaining cycles.

These methods add further tools to MIM SurePlan MRT to ensure clinicians have

the ability to perform dosimetry in situations where they are unable to obtain

multiple SPECT/CTs for patients.

"We've identified that two of the most common barriers for implementing

clinical dosimetry are resource management and logistics around obtaining

multiple image acquisitions," said Tim Adams, Nuclear Medicine Market Director

at MIM Software. "Our goal for these new additions to MIM SurePlan MRT is to

make capturing dosimetry practical for both clinics and patients by removing

some of the hurdles associated with conventional dosimetry approaches."

These new AI segmentation models may not be available in all countries. Check

with your local MIM Software representative for availability in your region.

About MIM Software Inc.

MIM Software Inc. is a privately held company with a dynamic working

environment. It is headquartered in Cleveland, OH, with international offices

in Beijing, Chengdu, and Brussels.

MIM Software sells its products globally to imaging centers, hospitals,

specialty clinics, research organizations, and pharmaceutical companies. The

company's products are used in over 3000 centers worldwide, with more than 500

of those centers located outside of the United States.

MIM Software Inc. is committed to enhancing patient care by providing

customer-centered and innovative imaging solutions in the fields of Radiology,

Nuclear Medicine, Neuroimaging, Cardiac Imaging, and Radiation Oncology.

To learn more, visit www.mimsoftware.com.

SOURCE MIM Software Inc.

CONTACT: Nick Sewell, +1-330-704-7738, nsewell@mimsoftware.com